Not applicableUnknownNCT05371392What this trial is testingPolymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Sohag University 80
Large-scale testing (Phase 3)Study completedNCT00719563What this trial is testingAmerican Ginseng in Treating Patients With Fatigue Caused by CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+7 more Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Early research (Phase 1)WithdrawnNCT02194374What this trial is testingAutologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia M.D. Anderson Cancer Center
Not applicableWithdrawnNCT04694560What this trial is testingA Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaWho this might be right forCLLSLLCLL/SLL+2 more Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03197259What this trial is testingChronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National StudyWho this might be right forChronic Lymphocytic LeukemiaDel(17P) Fatih Demirkan, MD 1,000
Early research (Phase 1)Study completedNCT03833180What this trial is testingZilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)Who this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaFollicular Lymphoma+9 more VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 91
Not applicableNot Yet RecruitingNCT07157579What this trial is testingNotch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma PatientWho this might be right forChronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL) Sohag University 80
Early research (Phase 1)Study completedNCT00769288What this trial is testingFAU in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00046488What this trial is testingSafety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Biogen 70
Early research (Phase 1)Study completedNCT00104923What this trial is testingFenretinide in Treating Patients With Refractory or Relapsed Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+1 more California Cancer Consortium 29
Testing effectiveness (Phase 2)Looking for participantsNCT06533579What this trial is testingGene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Who this might be right forB-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00027560What this trial is testingMelphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Memorial Sloan Kettering Cancer Center 51
Not applicableEnded earlyNCT04342117What this trial is testingObservational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FLWho this might be right forLymphoma, Small LymphocyticLymphomaLymphoma, Non-Hodgkin+2 more SecuraBio 2
Testing effectiveness (Phase 2)Study completedNCT00764517What this trial is testingVorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Indolent Adult Non-Hodgkin Lymphoma+1 more OHSU Knight Cancer Institute 57
Not applicableNot Yet RecruitingNCT07711327What this trial is testingAtrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor TherapyWho this might be right forAtrial Fibrillation (AF)Chronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia+2 more Tina Baykaner 500
Not applicableEnded earlyNCT04595851What this trial is testingPharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer MedicationsWho this might be right forChronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMultiple Chronic Conditions University of Michigan Rogel Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01082939What this trial is testingCyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 80
Early research (Phase 1)Ended earlyNCT02454270What this trial is testingA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more Janssen Research & Development, LLC 59
Not applicableLooking for participantsNCT06788639What this trial is testingPatients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing SettingWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 300